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Tissue macrophages are an important cellular reservoir for replication of human immunodeficiency virus
type 1 (HIV-1) and simian immunodeficiency virus. In vitro, the ability of macrophages to support viral rep-
lication is differentiation dependent in that precursor monocytes are refractory to infection. There is, however,
no consensus as to the exact point at which infection is restricted in monocytes. We have revisited this issue
and have compared the efficiencies of early HIV-1 replication events in monocytes and in differentiated mac-
rophages. Although virus entry in monocytes was comparable to that in differentiated macrophages, synthesis
of full-length viral cDNAs was very inefficient. Relative to differentiated macrophages, monocytes contained low
levels of dTTP due to low thymidine phosphorylase activity. Exogenous addition of D-thymidine increased dTTP
levels to that in differentiated macrophages but did not correct the reverse transcription defect. These results
point to a restriction in monocytes that is independent of reverse transcription precursors and suggest that
differentiation-dependent cellular cofactors of reverse transcription are rate limiting in monocytes.
The presence of an extravascular reservoir of human immu-
nodeficiency virus type 1 (HIV-1)-infected macrophages is well
established (6, 7, 10, 12, 30, 31). The ability of tissue macro-
phages to serve as a reservoir for HIV-1 and simian immuno-
deficiency virus replication correlates with the ability of mono-
cyte-derived macrophages to support productive viral infection
in vitro (reviewed in reference 10). Before entering the tissues
and differentiating into macrophages, monocytes briefly circu-
late in peripheral blood (28, 29). Several studies indicate that
circulating monocytes also serve as a viral reservoir in infected
individuals (15–17, 33). The infection of circulating monocytes
in vivo is at odds with in vitro studies, where monocytes acquire
the ability to support productive viral infection only after their
differentiation to macrophages (2, 4, 5, 19, 20, 23, 25). While
most studies have suggested that the viral replication cycle in
monocytes is restricted at a point prior to establishment of the
provirus, the exact point of restriction is a matter of debate.
Chemokine receptor expression has been shown to increase
during in vitro differentiation of monocytes, but this did not
account fully for differences in infectibility (4, 19). Macro-
phages from different donors have been shown to support
HIV-1 infection to highly variable degrees, but the ability to
support infection was independent of receptor/coreceptor ex-
pression and was manifest at the level of late reverse transcrip-
tion (5). HIV-1 pseudotyped with the envelope glycoprotein of
vesicular stomatitis virus (VSV) was also restricted in mono-
cytes (20), suggesting that the block is independent of viral
attachment and receptor/coreceptor factors. Some studies
have indicated that viral cDNA synthesis is extremely ineffi-
cient or completely absent in monocytes (5, 25). Other studies
using an HIV-1-based vector placed the block between com-
pletion of reverse transcription and nuclear entry of viral
cDNA (20). In this study we use quantitative entry and posten-
try assays to better define the point at which viral replication is
restricted in monocytes.
Culture of fresh monocytes in the presence of monocyte
colony-stimulating factor (MCSF) promotes monocyte differ-
entiation (9). To examine the kinetics of monocyte differenti-
ation, fresh elutriated monocytes were plated in the presence
of MCSF and immunophenotyped for expression of the lipo-
polysaccharide (LPS) receptor (CD14), the transferrin recep-
tor (CD71), and the hemoglobin scavenger receptor (CD163).
CD14 and CD163, which are expressed on monocytes and
macrophages differentiated in the presence of MCSF in vitro
(14, 27), were constitutively expressed during monocyte differ-
entiation (Fig. 1a). On the other hand, the percentage of cells
expressing the macrophage-specific transferrin receptor, CD71,
increased as cells underwent differentiation in culture (Fig. 1a).
We examined whether fresh monocytes supported HIV-1 entry
using a recently developed -lactamase-based HIV-1 entry
assay (1, 18). In this assay, the fluorescent substrate of -
lactamase (CCF2) is loaded into target cells. Cells are then
infected with a wild-type virus in which a Vpr–-lactamase
fusion protein has been packaged. Upon virus binding, fu-
sion, and uncoating, -lactamase, which is incorporated into
virions through fusion with Vpr, enzymatically cleaves the
-lactam ring in CCF2, changing its fluorescence emission
from green to blue. The assay does not score for virions that
have been taken up by endocytosis but depends on the
liberation of the Vpr–-lactamase fusion protein into the
cytoplasm after uncoating. Single-round infection of pri-
mary cells by HIV-1 is normally inefficient. Therefore, to
increase the number of infection events for analysis, fresh
monocytes were infected with VSV-G-pseudotyped and non-
pseudotyped HIV-1 (wild-type for Vpr). Both pseudotyped
and nonpseudotyped virions were able to infect fresh mono-
cytes, as evidenced by the presence of -lactamase activity
(Fig. 1b). Similar frequencies of -lactamase-positive cells
were observed following infection of fresh monocytes and
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7-day differentiated macrophages (Fig. 1b). These results
were representative of monocytes obtained from indepen-
dent donors (n  5). In comparison, quiescent lymphocytes,
which do not support productive infection, also supported
HIV-1 entry (Fig. 1b). VSV-G pseudotyping increased the
frequency of infected cells to similar levels in monocytes and
in differentiated macrophages (Fig. 1b). Therefore, events
leading up to uncoating appear to progress with similar
efficiencies in monocytes and in differentiated macrophages,
suggesting that the block to monocyte infection is at a point
in the viral replication cycle subsequent to virus binding,
fusion, and uncoating.
We next compared the abilities of monocytes and macro-
phages to support viral cDNA synthesis. Fresh monocytes were
plated in medium in the presence of MCSF to promote differ-
entiation. At daily intervals following initiation of the cultures,
monocytes were infected. Early (minus-strand strong-stop
cDNA) and late products of reverse transcription were mea-
sured 18, 42, and 66 h following infection by real-time PCR
quantitation of late reverse transcription products as well as
two-long-terminal repeat (2-LTR) circle forms of viral cDNA.
The presence of viral integrants was determined by an Alu-
LTR PCR method (8). In undifferentiated monocytes early
(not shown) and late (Fig. 2) reverse transcripts were synthe-
sized very inefficiently. As monocytes differentiated to macro-
phages, they acquired the ability to support HIV-1 reverse
transcription (Fig. 2). Expression of the macrophage marker
CD-71 became evident after 3 to 4 days in culture (Fig. 1a).
This was also the interval at which reverse transcription, based
on synthesis of late reverse transcripts and 2-LTR circles (Fig.
2a and b), became evident. These late reverse transcripts were
also competent for integration since we were able to detect the
presence of integrated proviruses at these intervals (Fig. 2c).
This pattern of reverse transcription in monocytes and macro-
phages was extremely consistent in cells from multiple donors
(n  6). These results suggest the presence of a reverse tran-
scription defect in monocytes that is alleviated upon differen-
tiation.
FIG. 1. Monocytes support HIV-1 entry. (a) Elutriated monocytes were cultured in the presence of MCSF, and, at daily intervals, cells were
removed and immunophenotyped for the indicated cell surface receptors by flow cytometry. ND, not done. (b) Efficiency of HIV-1 entry in
monocytes and macrophages. The extent of virus entry was examined as described elsewhere (1, 18). Briefly, monocytes and macrophages were
incubated with 2 nM CCF2/AM for 2 h and then infected with wild-type or VSV-G-pseudotyped HIV-1 virions into which a Vpr–-lactamase
fusion protein had been packaged. Two to 4 h postinfection, cells were examined by fluorescence microscopy using 424/444- and 516/520-nm
band-pass filters in order to discriminate infected from uninfected cells. The ability of resting lymphocytes, which are refractory to productive
HIV-1 infection, to support HIV-1 entry was compared with that of monocytes and macrophages. The effect of spinoculation (21) and Polybrene
(3) on the efficiency of monocyte and lymphocyte infection was also examined.
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FIG. 3. Analysis of dNTP levels in monocytes and differentiated macrophages. (a) dNTP levels were determined as described previously (24).
(b) De novo and salvage pathways for dTTP synthesis. (c) Levels of thymidine phosphorylase in monocytes and differentiating macrophages. Levels
of thymidine phosphorylase and the control proteins lamin B1 and actin were determined by Western blotting.
FIG. 2. Analysis of reverse transcription in infected monocytes and differentiated macrophages. At daily intervals following initiation of
monocyte cultures in MCSF, cells were removed and infected with a VSV-G-pseudotyped HIV-1. At 18, 42, and 66 h postinfection, total cellular
DNA was isolated and the presence of late reverse transcripts (a) and 2-LTR circle forms of viral cDNA (b) was determined by real-time PCR,
while integrated proviruses (c) were visualized by Alu-LTR PCR as described elsewhere (8).
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Previous studies have indicated that quiescent peripheral
blood lymphocytes, which are refractory to productive infec-
tion, inefficiently support reverse transcription (32). While it
was originally suggested that this was due to rate-limiting levels
of deoxynucleotide triphosphates (dNTPs), increasing dNTP
levels improved reverse transcription but did not overcome the
infectivity block (13). Comparison of dNTP levels in fresh
monocytes and in 7-day macrophages indicated only a twofold
difference in dATP, dGTP, and dCTP levels between mono-
cytes and macrophages (Fig. 3a). However, dTTP levels in
fresh monocytes were low to undetectable and increased upon
culture (Fig. 3a). For monocytes from four independent do-
nors, dTTP levels in monocytes were close to background and
increased over 10-fold upon macrophage differentiation. D-
Thymidine, the major biosynthetic precursor of dTTP, is de-
rived from thymine by the action of thymidine phosphorylase
(Fig. 3b). In cells from independent donors (n  3), this en-
zyme was present at low to undetectable levels in fresh mono-
cytes and was induced during differentiation to macrophages
(Fig. 3c). We examined whether artificially increasing dTTP
levels in fresh monocytes would overcome the reverse tran-
scription defect present in these cells. To increase dTTP levels,
fresh and 2-day monocytes were incubated with several dTTP
biosynthetic precursors. Addition of D-thymidine to fresh
monocytes was sufficient to increase dTTP concentration to
levels exceeding that of differentiated macrophages (Fig. 4a).
D-Uridine did not influence dTTP levels, while thymine in-
creased dTTP levels only in 2-day monocytes (Fig. 4a). This
was to be expected since thymidine phosphorylase, which is
required for conversion of thymine to D-thymidine, was more
abundant in monocytes that had been in culture for a least 2
days (Fig. 3c). Since dTTP levels could be stimulated to levels
comparable to that in fully differentiated macrophages (Fig.
3a), we examined whether this was sufficient to promote re-
verse transcription in fresh monocytes. Infection of monocytes
in the presence or absence of exogenous D-thymidine did not
have a significant impact on the extent of reverse transcription
whether infections were conducted with pseudotyped or with
nonpseudotyped viruses (Fig. 4b). Therefore, increasing dTTP
levels to that of differentiated macrophages was not sufficient
to significantly impact reverse transcription efficiency.
In this study we have attempted to characterize the point at
which monocyte infection by HIV-1 is restricted. Collectively,
our data suggest a reverse transcription defect in undifferen-
tiated monocytes that cannot be corrected by normalization of
dNTP levels. The restricted infection of fresh monocytes par-
allels that which has been described for quiescent T lympho-
cytes (13). Nuclear factor of activated T cells (NFAT) is
present at low levels in quiescent lymphocytes, and it has been
proposed that this accounts for the inefficient reverse tran-
scription in these cells (11). However, NFAT was not detect-
able in either fresh monocytes or in differentiated macro-
phages, so differences in NFAT expression could not account
for the observations reported in our study. It has been pro-
posed that inefficient reverse transcription due to low dNTP
levels accounts for the restriction to productive viral infection
of quiescent lymphocytes. However, although exogenous stim-
ulation of dNTP levels enhanced reverse transcription and
generation of full-length transcripts, this did not overcome the
block to infection. These and other studies (22, 26) support the
notion that a block subsequent to reverse transcription pre-
vents productive infection of quiescent lymphocytes. Upon in-
fection of monocytes, reverse transcription was highly ineffi-
cient when analyzed up to 66 h postinfection and was not
improved by normalization of dNTP levels (Fig. 2). This sug-
gests a reverse transcription block in monocytes rather than a
post-reverse transcription block. Therefore, for monocytes, dif-
ferentiation-dependent cellular factors important for reverse
transcription may be rate limiting while, for quiescent lympho-
cytes, activation-dependent cellular cofactors that regulate a
post-reverse transcription step in viral infection may be lacking.
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FIG. 4. Normalization of dTTP levels and effect on HIV-1 reverse
transcription. (a) Fresh monocytes (D0) and monocytes cultured for 2
days (D2) were incubated with D-thymidine (dT), D-uridine (dU), and
thymine (T) for 2 h, and dTTP levels were measured. (b) D0 mono-
cytes were incubated in the presence or absence of D-thymidine as for
panel a and then infected with wild-type or VSV-G-pseudotyped
HIV-1. Late reverse transcripts and 2-LTR circles were quantitated at
the indicated time intervals postinfection. Experiments were done with
monocytes from three independent donors (results from two donors
are shown).
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